Dr. Robert S Alter MD Medical Oncologist

Dr. Robert Alter is a medical oncologist in Hackensack, New Jersey. He is affiliated with multiple hospitals in the area, including Hackensack University Medical Center and Holy Name Medical Center. He received his medical degree from Rosalind Franklin University of Medicine and Science and has been in practice for 26 years. Dr. Alter accepts several types of health insurance, listed below. He is one of 8 doctors at Hackensack University Medical Center and one of 4 at Holy Name Medical Center who specialize in Medical Oncology. He also speaks multiple languages, including Hebrew.

Are you Dr. Robert Alter? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology

Hospital Affiliation

Hackensack University Medical Center
Ranked #35 in Cancer

Holy Name Medical Center

Education & Medical Training

St Luke's-Roosevelt Hospital Center
Residency, Internal Medicine, 1988 - 1991

New York University School of Medicine
Fellowship, Hematology, 1991 - 1992

New York University School of Medicine
Fellowship, Medical Oncology, 1992 - 1994

Rosalind Franklin University of Medicine and Science
Class of 1988

Certifications & Licensure

American Board of Internal Medicine
Certified 25 years in Internal Medicine

American Board of Internal Medicine
Certified 21 years in Cardiovascular Disease

American Board of Internal Medicine
Certified 20 years in Clinical Cardiac Electrophysiology

MA State Medical License
Active through 2014

FL State Medical License
Active through 2015

Publications & Presentations

A urologic perspective on management of localized and metastatic RCC.
Jain, S., Alter, R. S., Sawczuk, I.

Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab.
Goldberg, S.L., Pecora, A.L., Alter, R.S., Kroll, M.S., Rowley, S.D., Waintraub, S.E., Imrit, K., Preti, R.A.

Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanoma.
Chachoua, A., Oratz, R., Liebes, L., Alter, R. S., Felice, A., Peace, D., Vilcek, J., Blum, R. H.

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • Anthem PPO
  • BCBS Blue Card PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Cofinity PPO
  • First Choice
  • First Health PPO
  • Great West PPO
  • HIP of New York - Select PPO
  • Horizon BCBS Direct Access
  • Horizon BCBS HMO
  • Horizon BCBS POS
  • Horizon BCBS PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • Oxford Health Freedom
  • Oxford Health Liberty
  • Premera BCBS Heritage & Heritage Plus 1
  • Providence Health System Personal Option
  • QualCare HMO
  • QualCare PPO
  • Rocky Mountain Group/Indiv - HMO/Private Pay
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.